We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+31.56%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$3.85B
AUM Growth
+$916M
(+31%)
Cap. Flow
+$277M
Cap. Flow
% of AUM
7.2%
Top 10 Holdings %
Top 10 Hldgs %
72.18%
Holding
59
New
10
Increased
9
Reduced
4
Closed
8
Top Buys
| 1 |
argenx
ARGX
|
+$140M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$92.7M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$80.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$79.9M |
| 5 |
Tango Therapeutics
TNGX
|
+$40M |
Top Sells
| 1 |
Revolution Medicines
RVMD
|
+$131M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$80M |
| 3 |
Relay Therapeutics
RLAY
|
+$35M |
| 4 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$30.2M |
| 5 |
SLRN
ACELYRIN
SLRN
|
+$14.3M |
Sector Composition
| 1 | Healthcare | 99.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1
DELISTED
Apellis Pharmaceuticals
APLS
| $669M | 17.37% |
11,173,068
+273,209
| +3% | +$13.9M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $435M | 11.28% |
7,396,979
+1,648,580
| +29% | +$92.7M |
|
3
Prothena Corp
PRTA
$450M
| $421M | 10.93% |
11,584,280
| – | – |
|
4
Arvinas
ARVN
$530M
| $277M | 7.19% |
6,726,491
+1,259,428
| +23% | +$29.4M |
|
|
LKFT
5
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $234M | 6.08% |
5,756,268
| – | – |
|
6
Acadia Pharmaceuticals
ACAD
$4.45B
| $188M | 4.87% |
5,991,479
| – | – |
|
7
AnaptysBio
ANAB
$1.67B
| $161M | 4.18% |
7,521,024
| – | – |
|
8
Zymeworks
ZYME
$1.81B
| $140M | 3.62% |
13,437,473
| – | – |
|
|
9
Tango Therapeutics
TNGX
$4.92B
| $132M | 3.43% |
13,330,736
+4,609,100
| +53% | +$40M |
|
|
10
Jazz Pharmaceuticals
JAZZ
$15.1B
| $125M | 3.24% |
1,013,952
+645,541
| +175% | +$80.6M |
|
|
11
argenx
ARGX
$54B
| $115M | 2.97% |
+300,997
| New | +$140M |
|
12
Xencor
XNCR
$1.1B
| $112M | 2.91% |
5,282,516
| – | – |
|
13
Kura Oncology
KURA
$1B
| $83.5M | 2.17% |
5,806,871
| – | – |
|
|
14
Sarepta Therapeutics
SRPT
$1.84B
| $80.3M | 2.09% |
+832,907
| New | +$79.9M |
|
15
Crinetics Pharmaceuticals
CRNX
$8.88B
| $71.6M | 1.86% |
2,012,517
+482,254
| +32% | +$14.8M |
|
|
MRSN
16
DELISTED
Mersana Therapeutics
MRSN
| $44.9M | 1.17% |
774,588
| – | – |
|
|
CNTA
17
DELISTED
Centessa Pharmaceuticals
CNTA
| $44.7M | 1.16% |
5,618,779
| – | – |
|
18
Immunome
IMNM
$2.57B
| $41.5M | 1.08% |
+3,879,415
| New | +$32.3M |
|
19
Edgewise Therapeutics
EWTX
$4.35B
| $38.2M | 0.99% |
3,493,194
| – | – |
|
20
Neumora Therapeutics
NMRA
$304M
| $35.3M | 0.92% |
2,071,450
| – | – |
|
|
THRD
21
DELISTED
Third Harmonic Bio
THRD
| $34.9M | 0.91% |
3,182,444
+200,000
| +7% | +$1.58M |
|
22
Voyager Therapeutics
VYGR
$192M
| $32.5M | 0.84% |
3,851,507
| – | – |
|
23
Alector
ALEC
$164M
| $32.4M | 0.84% |
4,056,548
| – | – |
|
24
Oric Pharmaceuticals
ORIC
$1.15B
| $31.4M | 0.82% |
3,418,068
| – | – |
|
25
TScan Therapeutics
TCRX
$60.9M
| $29.1M | 0.76% |
5,000,000
| – | – |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM